Internet of Things (IoT) in Healthcare is fastest growing segment fueling the growth of Antiviral Drugs market
The global Antiviral Drugs Market is estimated to be valued at US$ 61324.71 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Antiviral drugs are used to treat viral infections by either inhibiting viral
replication or destroying infected host cells.The emergence of new viruses and
increasing resistance to existing antiviral drugs are major factors driving the
need for effective antiviral therapies.
Market key trends:
One of the key trends in the antiviral
drugs market size is the growing demand for long acting antiviral
therapies. Long acting antiviral drugs have less frequent dosing schedules
compared to conventional therapies. This improves patient adherence and
clinical outcomes. Another major trend is the increasing focus on developing
broad spectrum antiviral drugs that are effective against a wide range of
influenza viruses. This is important considering rapid viral mutations.
Development of nanomedicine based antiviral drug delivery is another emerging
trend, offering enhanced pharmacological properties and targeting ability.
Segment Analysis
The global antiviral drugs market is segmented into drugs, application,
distribution channel and region. Based on drugs, the market is segmented into
branded and generic. The generic drugs segment dominated the market in 2021 and
is expected to witness highest growth during the forecast period due to lower
cost and easy availability of generics as compared to branded drugs.
Key Takeaways
The global antiviral drugs market size was valued at US$ 61324.71 Mn in 2023
and is expected to grow at a CAGR of 4.2% during the forecast period. The
market is expected to witness high growth due to increasing prevalence of
HIV/AIDS, influenza and hepatitis infections globally.
North America dominated the global antiviral drugs market in 2021 owing to
growing incidence of infectious diseases and presence of major market players
in the region. However, Asia Pacific is expected to exhibit the fastest CAGR
over the forecast period due to improving healthcare infrastructure and
increasing healthcare spending in major markets like China and India.
Key players operating in the antiviral drugs market include GlaxoSmithKline
plc, AbbVie Inc., Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., F.
Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Johnson & Johnson
Services, Inc., Cipla Inc., Aurobindo Pharma, and Gilead Sciences.
GlaxoSmithKline plc dominates the global market owing to its diverse product
portfolio for treating viral infections.
Get
more insights on this topic: https://www.newsstatix.com/antiviral-drugs-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment